The COVID-NMA initiative
A living mapping and living systematic review of Covid-19 trials
COVID-NMA is an international research initiative supported by the WHO and Cochrane.
We provide a living mapping of COVID-19 trials. We are also conducting living evidence synthesis on preventive interventions, treatments and vaccines for COVID-19 to assist decision makers.
See the description of our model here and our living review protocol here.
LIVING MAPPING OF TRIALS
(i.e., trials registered on the WHO platform)Updated weekly
4540
Randomized Trials
1200 RCTs recruiting
LIVING SYNTHESIS OF PUBLISHED STUDIES
(include both articles and preprints)Updated daily
845
Studies (RCTs or Observational studies) with complete data extraction and results
included in our evidence synthesis
meta-COVID
Of note, as of March 1, 2022, the COVID-NMA revised its protocol and reduced its scope.
Only comparisons evaluating antivirals, immunomodulators and COVID-19 vaccines will continue to be updated every two weeks
Perform your own analysis using COVID-NMA data, create and download your forest plots by clicking below:
Summary of Main Results
Summary of the evidence for pharmacological treatment of hospitalized COVID-19 patients identified up to October 17, 2022 is available below.
As of October 2022, it will be updated every three months.
For earlier editions of the summary of main results, click here
BI-WEEKLY UPDATE
October 21 to November 3. See the update here.
Newsletter
To receive updates on our project, please subscribe below.
Excluded Studies
Download CSV file (last update: 2022-09-20).
Retracted Studies
Download CSV file (last update: 2022-09-15).